|
|
| CrossRef Text and Data Mining | |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. | |
| Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Multilevel Posterolateral Lumbar Fusion in a Prospective, Randomized, Controlled Trial | |
| Ho Yong Choi, Seung-Jae Hyun, Chang Hyun Lee, Ji Hyun Youn, Mi Young Ryu, Ki-Jeong Kim | |
|
Neurospine. 2022;19(3):838-846. Published online September 30, 2022 DOI: https://doi.org/10.14245/ns.2244464.232 |
|
|
Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Multilevel Posterolateral Lumbar Fusion in a Prospective, Randomized, Controlled Trial Neurospine. 2022;19(3):838-846  Two-year follow-up of a safety and efficacy study of osteoinductive protein–1 (recombinant human bone morphogenetic protein–7) as an adjunct to posterolateral lumbar fusion The Spine Journal. 2002;2(2):8 A pilot safety and efficacy study of osteoinductive protein–1 (recombinant human bone morphogenetic protein–7) in posterolateral lumbar fusion as a replacement for iliac crest autograft The Spine Journal. 2002;2(2):9 Efficacy and safety of escherichia coli-derived recombinant human bone morphogenetic protein-2 in additional posterolateral lumbar fusion: Minimum 1 year follow-up Brain and Spine. 2021;1:100094 Efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in additional lumbar posterolateral fusion: minimum 1-year follow-up The Spine Journal. 2021;21(8):1340-1346 Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-blinded, open-label, multicenter trial Journal of Orthopaedic Surgery and Research. 2022;17(1): Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Posterolateral Lumbar Spine Fusion: Complications in the Elderly The Spine Journal. 2011;11(10):S61-S62 A prospective evaluation of allograft bone versus titanium cylindrical cages for anterior lumbar fusion using recombinant human bone morphogenetic protein–2 The Spine Journal. 2002;2(2):28 Efficacy of Escherichia coli -derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial The Spine Journal. 2017;17(12):1866-1874 Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. Dawson E, Bae HW, Burkus JK, Stambough JL, Glassman SD. J Bone Joint Surg Am. 2009;91(7):1604–13 The Spine Journal. 2010;10(3):275-276 |
